Scott Stromatt - Net Worth and Insider Trading
Scott Stromatt Net Worth
The estimated net worth of Scott Stromatt is at least $73 dollars as of 2025-01-19. Scott Stromatt is the EVP, Clinical Dev & Reg Affair of CTI BioPharma Corp and owns about 8 shares of CTI BioPharma Corp (CTIC) stock worth over $73. Details can be seen in Scott Stromatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Stromatt has not made any transactions after 2005-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Stromatt
Scott Stromatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Stromatt owns 1 companies in total, including CTI BioPharma Corp (CTIC) .
Click here to see the complete history of Scott Stromatt’s form 4 insider trades.
Insider Ownership Summary of Scott Stromatt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2005-08-19 | EVP & Clinical Dev & Reg Affair |
Scott Stromatt Latest Holdings Summary
Scott Stromatt currently owns a total of 1 stock. Scott Stromatt owns 8 shares of CTI BioPharma Corp (CTIC) as of August 19, 2005, with a value of $73.
Latest Holdings of Scott Stromatt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2005-08-19 | 8 | 9.09 | 73 |
Holding Weightings of Scott Stromatt
Scott Stromatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Stromatt has made a total of 0 transactions in CTI BioPharma Corp (CTIC) over the past 5 years. The most-recent trade in CTI BioPharma Corp is the sale of 0 shares on August 19, 2005, which brought Scott Stromatt around $0.
Insider Trading History of Scott Stromatt
- 1
Scott Stromatt Trading Performance
Scott Stromatt Ownership Network
Ownership Network List of Scott Stromatt
Ownership Network Relation of Scott Stromatt
Scott Stromatt Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Scott Stromatt is the EVP & Clinical Dev & Reg Affair of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Scott Stromatt Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Stromatt. Currently GuruFocus does not have mailing address information for Scott Stromatt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
